Enhances iQ platform with new glass syringe for sensitive drugs
Re-ups 10-year NIH contract to support the Blueprint Neurotherapeutics Network
Adents Prodigi was developed in collaboration with Microsoft
Innovations include single-use tangential flow filtration capsule for bioprocessing of ADCs and monoclonal antibodies
Visit Booth 1129 at Interphex 2018 to learn more about the complete suite of drug development and manufacturing solutions
Betsy is focusing on expanding Contract Pharma’s video and social media presence
Dr. Wang brings more than 20 years of leadership experience in the biotechnology and manufacturing industry
Completes $5.5 million expansion of clinical storage at Philadelphia facility
West will distribute Ompi EZ-fill vials in North America
For BioThrax (Anthrax Vaccine Adsorbed) in five Concerned Member States (CMS) within the European Union (EU)
Will address surface selection criteria to meet rigorous pharmaceutical production standards
Will build new state-of-the-art laboratory to support its growing pharmaceutical and medical device client base
Houston site will produce treatments for rare genetic disorders and life-threatening diseases
Robert G. Kramer Sr. will serve as president and COO, and Richard S. Lindahl will serve as EVP and CFO
New plasma products and technology company-Evolve Biologics-led by Blaine Forshage as CEO
New 150,000 sq.-ft. complex will house the company's process development labs and corporate administrative offices
Orkila to promote Capsugel capsule range in Egypt
Significant expansion of analytical laboratories at its center of excellence for contained manufacturing
Makes major land purchase in Grand Rapids to expand manufacturing footprint
New German site will support complex clinical research and bring more than 200 new jobs to community
Discover the latest in pharma and biopharma manufacturing technology and trends
Filling and stoppering machine for nested syringes able to produce up to 12.000 pieces/h
Adds the Colanar FSV syringe filler at Grand Rapids site
Invests in HP Indigo 5900 Digital Press
Green-chemistry progesterone synthesis reduces carbon footprint by more than 70%
Focused on the automation of biopharmaceutical processes for China’s biopharmaceutical industry
inSPIRE vertical modular robotic platform designed to integrate multiple instruments in a space-saving solution
Maintains Bausch + Ströbel partnership
Aims to address the difficulty swallowing oral solid dosage forms
Adds new research and development, customer demonstration labs, and manufacturing space
Clinical Supply Facility provides additional GMP space for secondary packaging
Their container closure integrity testing is specifically expanding into the European Union
Facility has 180,000 liters total capacity and is expected to be cGMP operational by 4Q18
Will use Catalent's Zydis for the development of Biohaven's lead CGRP receptor antagonist product candidate
A new suite added that facilitates encapsulation of highly potent compounds
Dixon to oversee Analytical Testing & Development groups and Microbiological & Raw Material Testing Labs
Graham Reynolds of West discusses the latest drug delivery strategies and trends
Aims to allow clients rapid access and visualization into their ongoing projects
Matt Halvorsen will remain as LSNE’s chief executive
Facility will be used for injectable elastomeric component manufacturing
Designed to protect humidity-sensitive products that require special handling
Designed to provide more flexibility, better supply predictability and shorter lead times for drug manufacture
Invests in multiple highly sensitive and selective LC-MS/MS instruments
New Year, New Administration, New Challenges: Where is the Industry Going?
Adds contract manufacturing of highly potent solid oral dose at Ireland facility
Establishes Phase I patient unit at Medical Center of Defense Hospital in Budapest, Hungary
Invests in Bruker's D8 Discover HTS System for high-throughput X-Ray diffraction screening
German Federal Ministry of Health approves the company’s Michigan facility for large-scale manufacturing
Adds staff and critical instrumentation to the E&L group
Will offer service for formulating, filling, freeze-drying and packaging injectable drugs for clinical trials
Companies fluorinated molecules serve as building blocks for pharmaceutical products
CDMO provides turnkey contract manufacturing and packaging for oral solid and liquid dosage delivery systems
Dr. Stein joined FDA in late 2016 as the deputy director at the OND, CDER
Full schedule features more than 30 sessions
Panel of pharma execs to discuss strategies for diversity and the vital role of women executives in progressive organizations
Digital health leader Nik Leist to present second CPhI North America keynote address
Will explore convergence of digital health, communications and patient-led changes
Global pharmaceutical companies outsource topical products to the growing CDMO
Betsy is focusing on expanding Contract Pharma’s video and social media presence
The site will support the U.S. government’s national security and public health emergency needs
Company’s silicone chemistries target cost control, product differentiation and solubility challenges
Part of a broader global investment initiative in testing capabilities
Bristol facility grows from a $25 hand-operated tablet machine to a 500,000 square-foot campus
CHOZN expression system to be used to accelerate development timelines
Increases High Point, NC, facility reactor capacity by 30%
Will advance clinical development of innovative protein therapy for achondroplasia
Reinforces a long-standing partnership between Aptar Pharma and Takeda
Development doubles site capacity of Bridgend Center of Excellence
Provides entry into the high-growth CDMO market
Establishes commercial-ready gene therapy supply for the industry
Will be dedicated to the development, reformulation, and manufacturing of drug products in pediatric dosage forms
To provide commercial supply of first-in-class oral therapy from its Kansas City facility
Invests $26 million in new sterile PDS suite
Will create a vertically integrated, global player in manufacturing and supply chain solutions
Will continue to expand its filling and freeze-drying capabilities
Implements Adents Seriza for DSCSA compliance
To provide drug substance development and manufacturing services
Oral solid-dose facility in Greenville, NC, is complete
Expands options for controlled-release parenteral drug formulations
Will also present 26 scientific posters on a range of topics
Will develop and manufacture clinical supplies for a new treatment for beta-thalassemia
New identity depicts extended range of services following acquisitions of Co-Formulate, QS Pharma and SeaView Research
Makes another investment in fully contained Xcelodose 600S technology
To manufacture Solasia's Darinaparsin API at CoE in Germantown, WI
Operating companies Nelson Labs, Nordion and Sterigenics, will maintain their names
Newly expanded API manufacturing synthesis capabilities brings capacity to more than 3 Mol
Establishes joint lab to develop full continuous processing for the manufacture of monoclonal antibodies
Acquisition creates leading extractables and leachables lab testing platform
Evonik to provide APIs and intermediates for use in key Lilly products
Sessions address Pharmaceutical Excipients, Emerging Partnership Models, Drug Delivery Strategies, and more
To offer more clinical trial services as well as high potency compounds
Significant global expansion of existing analytical services
Will provide clinical research services to support Division of AIDS
Will leverage GPEx cell line technology to develop cell lines and manufacture antibodies for optimization
Recommended for non-absorbed drugs, topicals, emulsions and suspensions, and multi-strength product equivalence
See the show floor and get session highlights on key topics
Trilli will coordinate and organize initiatives in sustainability and maximizing social impact
Adds capacity to produce biodegradable polymers
A solution to the November 2017 mandate
Emergent gains exclusive rights to IBT's vaccine antigens to develop and manufacture Filovirus vaccine
Adds new manufacturing facility in Milford, expands drug product capacity in Irvine
Aims to employ 5,000 globally by 2017
Auryxia is now available for prescription in the U.S.
Adds SPX Anhydro MicraSpray 150 at San Diego facility
Aims to address enhanced regulation of metals and impurities in pharmaceuticals
Now manufactures its major brands of excipients in Nanjing to better serve China’s burgeoning pharma industry
To invest $34M and add 2 x 2,000 liter SUB system and lab space
Becomes first facility in India to be equipped with the RapidFire Mass Spec technology
Enhances inhalation, small and large molecule analytical testing
Catalent to provide fill-finish production services for biosimilar to Enbrel
Plans call for the opening of a 500 square meter facility next month
Designed to support cGMP clinical manufacturing of Moderna’s mRNA personalized cancer vaccine
Provides a three-year continuation for early discovery services
R&D provider joins NC Research Campus, expands dermatological development capabilities
Study provides observed link between DNA repair deficiency and activation of the immune checkpoint PD-L1
To manufacture cell therapy products that use viral vectors, such as CAR T cell therapies
Aims to develop industrial-scale bioprocess solutions for the manufacture of stem cell-based therapies
Aims to support a backup supply option for potential clinical, launch and commercial supply
Will provide DNA sequencing services using the Sanger method to researchers throughout Canada
Will potentially expand the workforce and capacity by one-third
To install spray-drying unit and Xcelodose 600S Micro-Dosing System at Ploërmel, expands commercial manufacturing for LBFs
Serialization partners launch new plug-in to improve production efficiency
Invests £6 million to strengthen and expand its milling, micronization and solid form capabilities
The 5,800 sq. m. facility will become one of the largest testing sites of its kind in the UK
Company now holds ATEX, IEC and Ex equipment certification
Offers five packaging solutions to meet a range of needs
Expands selectAZyme enzyme platform to include over 4,000 unique enzymes
Adds Accountability and Reconciliation Tracking (ART)
Regulation shifting due to increased data dependence, regulatory oversight is slowing six sigma, forecasts generic growth
Establishes two new business units for Biologics and Oral Drug Delivery
Will invest €4 million to expand cGMP capacity for clinical and commercial supply of APIs at its Chasse-sur-Rhône facility
Will produce upwards of 2 billion pieces of pharmaceutical packaging per year
New glass lined reactors bring the cGMP capacity to 23,000 gallons
Follows the CDMO’s €40M investment into its company-wide implementation program last year
Can develop, make and pack non-potent and potent, solid orals for clinical trials and commercial supply
Site will provide in-country manufacture of highly potent oral solid dosage forms
Experts predict PAT/QbD and CM adoption may take ten years
Provides a home base for local customers interested in developing and manufacturing products for launch in the U.S.
Niche services and technologies to dominate future acquisitions, increase in flow chemistry, fermentation anticipated
Will develop a novel and differentiated challenge model for respiratory syncytial virus
New regulatory requirements drive increase in analytical testing services
Offers pharmaceutical glass products for parenteral drug market
Invests in generic API development and manufacturing at its Milan site
54,000 square foot facility has production capabilities ranging from very small-scale up to 3,000 liters
The world of pharma returns to Frankfurt
Protectionism, consolidation, immigration, drug pricing and regulatory issues
Site adds early-phase clinical manufacture on the West Coast
Broadens the CDMO’s pre-clinical and clinical offering to include bioanalytical and drug discovery services.
Will add multi-purpose plants, with more than 270kL of total capacity
Emergent BioSolutions provides contract mfg services for both bulk drug substances and sterile injectable drug products
Expands capacity with secondary solid dosage form manufacturing, packaging and distribution site
Adds presence in Ireland and expands commercial and clinical capabilities
Federal Equipment Company offers 60 years of expertise buying and selling pharmaceutical processing and packaging equipment.
PPS is a turn-key contract packager offering bottling, blister packaging, folding carton production, kitting, and more
We are a leading contract development and manufacturing organization (CDMO)
Ongoing investment strategy to further develop sites and make additional manufacturing capacities available
Enlists the help of German machine maker in latest €19M investment in Swiss facility
Dutch contract packager capable of process 13,000 tablets per minute
Expands biologics development and analytical services, manufacturing, and finished product supply
Will develop treatment for cyanide exposure together with Southwest Research Institute
Will offer solid-state chemistry, analytical and formulation development, and early-phase clinical supply manufacturing
Thank you sponsors, exhibitors and attendees for making the conference a huge success!
Development and manufacture of drug candidate KAND567 to take place in Solna, Sweden
Invests $5.5 million in Philadelphia site to increase clinical storage capacity
Will develop treatment for cyanide exposure together with Southwest Research Institute
Opens cell culture process development laboratories in Wilton Centre
Demand for end-to-end services spurs decision to expand
Will manufacture lofexidine, an investigational drug under development to mitigate symptoms associated with opioid withdrawal
Accelerates expansion of its global biologics platform
Supporting the development and commercialization of all facets of drug substance, product
MilliporeSigma to provide access to process development tools, education programs and training
Owen will oversee Q Laboratories’ Quality Assurance Unit
Gains next-gen processing technology platform
Optima VFVM 7000 allows for larger batch sizes and a broader range of filling volumes
Designed to deliver clinical trial supplies for time critical studies as fast as possible
Passes series of tests with the EMVO for connection to the European Hub for serialization offering
Analytical Research and Development and Quality Control labs have doubled in size and expanded service offerings
Doubles the site’s current footprint for a range of services
Aims to advance vaccine research and development for neglected and emerging infections
Broadens Baxter’s presence in the generic pharmaceuticals space
Represents an innovative new concept in biological manufacturing and development
Tie-up creates a full service CDMO
Aims to achieve change in biopharmaceutical yield and quality by improving product stability during downstream processing
Aims to provide students with an overview of the drug development process from concept to commercialization
Anticipates having all of its clients' products serialized by the November 2017 deadline
McClintock to lead the contract pharmaceutical development and manufacturing division
Purchases two buildings in Cincinnati as part of its ongoing capacity expansion
Aims to identify and address the challenges associated with pediatric formulation and drug delivery
Establish industrial manufacturing capabilities for a novel prostate cancer product
Designed to offer easier path from late-stage discovery to phase I clinical trials
Plans call for the relocation of global headquarters to Research Triangle Park in 2018
Master services and clinical supply agreement to enable process development and manufacturing by Abzena
Adds 20,000 sq.-ft. of manufacturing and office space in Milford, MA
Next-gen OTC pain relief product will feature OptiGel Mini technology